C3-convertase inhibitors for the prevention and treatment of age-related macular degeneration in patients with at risk variants of complement factor H

• 1. 用于在具有补体因子H的风险变体的患者中预防和治疗年龄相关性黄斑变性的C3－转化酶抑制剂 [P] . 中国专利： CN101346473A . 2009-01-14
• 2. 神经生长因子产生抑制剂、以及配合有该神经生长因子产生抑制剂的皮肤外用剂、化妆品、医药部外品、瘙痒预防和治疗剂、以及特异性皮炎治疗剂 [P] . 中国专利： CN100574769C . 2009.12.30
• 3. C3-convertase inhibitors for the prevention and treatment of age-related macular degeneration in patients with at risk variants of complement factor H [P] . AU2006330501B2 . 2012-04-05

  机译： C3转化酶抑制剂用于预防和治疗具有补充因子H风险变异体的老年性黄斑变性

• 4. C3-CONVERTASE INHIBITORS FOR THE PREVENTION AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION IN PATIENTS WITH AT RISK VARIANTS OF COMPLEMENT FACTOR H [P] . ZA200805148B . 2009-12-30

  机译： C3转化酶抑制剂在补充因子H风险高的患者中预防和治疗年龄相关性黄斑变性

• 5. C3-CONVERTASE INHIBITORS FOR THE PREVENTION AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION IN PATIENTS WITH AT RISK VARIANTS OF COMPLEMENT FACTOR H [P] . 世界知识产权组织专利： WO2007076437A3 . 2008-01-31

  机译： C3转化酶抑制剂在补充因子H风险高的患者中预防和治疗年龄相关性黄斑变性

• 1. Risk Factors for Age-Related Macular Degeneration in Elderly Chinese Population in Shenyang of China [J] . JIA LiHong, SHEN XueLi, FAN Rui, 生物医学与环境科学（英文版） . 2011,第005期
• 2. Individualized treatment with aflibercept in age-related macular degeneration patients with early persistent retinal fluid [J] . Alfredo Garca-Layana, Manuel Saenz-de-Viteri 眼科学报（英文版） . 2016,第004期
• 3. Recent Developments in the Treatment of Wet Age-related Macular Degeneration [J] . Zois Papadopoulos 当代医学科学(英文) . 2020,第005期
• 4. Further support for the common variants in complement factor H (Y402H) and LOC387715 (A69S) genes as major risk factors for the exudative age-related macular degeneration. [J] . Shastry BS Ophthalmologica: International Journal of Ophthalmology=Journal International d'Ophtalmologie . 2006,第5期
• 5. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration. [J] . Schaumberg DA, Christen WG, Kozlowski P, Investigative ophthalmology & visual science . 2006,第6期
• 6. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration. [J] . Schaumberg DA, Christen WG, Kozlowski P, Investigative ophthalmology & visual science . 2006,第6期
• 7. IS LIGHT WITH LACK OF RED SPECTRAL COMPONENTS A RISK FACTOR FOR AGE-RELATED MACULAR DEGENERATION (AMD)? [C] . Schierz C. Session of the CIE . 2019
• 8. Synthesis of Nonretinoid Inhibitors of RPE65 for the Potential Treatment of Dry Age-Related Macular Degeneration and Stargardt Disease [D] . Wang, Ivan E. 2020
• 9. A Prospective Assessment of the Y402H Variant in Complement Factor H Genetic Variants in C-reactive Protein and Risk of Age-Related Macular Degeneration in Men [O] . Debra A. Schaumberg, William G. Christen, Piotr Kozlowski, -1
• 10. A Prospective Assessment of the Y402H Variant in Complement Factor H, Genetic Variants in C-Reactive Protein, and Risk of Age-Related Macular Degeneration [O] . Debra A. Schaumberg, William G. Christen, Piotr Kozlowski, 2006

• 1. Brazilian Maize Landraces Silks as Source of Lutein: An Important Carotenoid in the Prevention of Age-Related Macular Degeneration [J] . Shirley Kuhnen ,Paulo Fernando Dias ,Juliana Bernardi Ogliari . 食品与营养科学（英文） . 2012,第11期
• 2. Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration [J] . Jing Wang ,Xiang Shi ,Qiyu Bo . 亚洲药物制剂科学(英文) . 2021,第5期
• 3. 肿瘤坏死因子转化酶(TACE)抑制剂研究进展 [C] . 李棉亮 ,李洪明 ,郭欣 . 第十一届全国抗生素(微生物药物)学术会议 . 2009
• 4. 新型选择性肿瘤坏死因子-α转化酶抑制剂的HPLC筛选方法的研究 [A] . 申玲玲 . 2008